BIOVENTUS INC. Cost, Amortization
BIOVENTUS INC. (BVS) reported Cost, Amortization of $22.08 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSoldAmortization · last filed 2026-03-05
- BIOVENTUS INC. cost, amortization for fiscal 2025 was $22.08M, a 11.11% decline from fiscal 2024.
- BIOVENTUS INC. cost, amortization for fiscal 2024 was $24.84M, a 4.16% increase from fiscal 2023.
- BIOVENTUS INC. cost, amortization for fiscal 2023 was $23.85M, a 13.70% increase from fiscal 2022.
- BIOVENTUS INC. cost, amortization for fiscal 2022 was $20.98M, a 72.22% increase from fiscal 2021.
| Period end | Cost, Amortization 12 month |
|---|---|
| 2025-12-31 | $22.08M 10-K · filed 2026-03-05 |
| 2024-12-31 | $24.84M 10-K · filed 2026-03-05 |
| 2023-12-31 | $23.85M 10-K · filed 2026-03-05 |
| 2022-12-31 | $20.98M 10-K · filed 2025-03-11 |
| 2021-12-31 | $12.18M 10-K · filed 2024-03-12 |
| 2020-12-31 | $7.46M 10-K · filed 2023-03-31 |
| 2019-12-31 | $6.42M 10-K · filed 2022-03-11 |